Literature DB >> 2329261

Acute withdrawal of short-term or prolonged L-triiodothyronine administration to thyroidectomized rats results in similar rapid increases in TSH beta mRNA.

D S Ross1, A Cohen.   

Abstract

In man, following the treatment of hyperthyroidism, or the withdrawal of prolonged suppressive thyroid hormone therapy, recovery from thyrotrope suppression may not occur until thyroid hormone concentrations have been subnormal for several weeks. Short-term studies in rodents have demonstrated a rapid increase in TSH synthesis after the acute withdrawal of thyroid hormones. We treated thyroidectomized rats with supraphysiologic doses of 1-triiodothyronine (T3) for 67 days, then abruptly withdrew treatment and compared the time course of thyrotrope recovery to that in animals given T3 for only 10 days. Increases in TSH beta mRNA after abruptly stopping T3 were qualitatively similar in both groups. After short-term T3 administration, TSH beta mRNA was detectable on the second day after stopping T3 administration and rose an additional 10-fold by day 5. After prolonged T3 administration, TSH beta mRNA was barely detectable on the second day after stopping T3 administration, clearly detectable on the third day, and increased an additional 20-fold by day 7. Compared to animals who received T3 for only 10 days, suppression of the thyrotrope by T3 administration for 67 days resulted in a nonsignificant delay in TSH beta mRNA synthesis of 24 h or less following the abrupt withdrawal of thyroid hormone. It is possible that differences in rat and human thyrotrope responsiveness account for the apparently different biologic behavior.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2329261     DOI: 10.1007/bf03349534

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  Regulation of the alpha and thyrotropin beta-subunit messenger ribonucleic acids by thyroid hormones.

Authors:  W W Chin; M A Shupnik; D S Ross; J F Habener; E C Ridgway
Journal:  Endocrinology       Date:  1985-03       Impact factor: 4.736

2.  Measurement of thyrotropin in clinical and subclinical hyperthyroidism using a new chemiluminescent assay.

Authors:  D S Ross; L J Ardisson; M J Meskell
Journal:  J Clin Endocrinol Metab       Date:  1989-09       Impact factor: 5.958

3.  Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosis.

Authors:  A D Toft; W J Irvine; W M Hunter; J G Ratcliffe; J Seth
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

4.  Serum thyrotropin (TSH) levels after thyroid ablation compared with TSH levels after exogenous bovine TSH: implications for 131-I treatment of thyroid carcinoma.

Authors:  J M Hershman; C L Edwards
Journal:  J Clin Endocrinol Metab       Date:  1972-05       Impact factor: 5.958

5.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy.

Authors:  A G Vagenakis; L E Braverman; F Azizi; G I Portinay; S H Ingbar
Journal:  N Engl J Med       Date:  1975-10-02       Impact factor: 91.245

7.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

8.  Analysis of factors in hyperthyroidism, which determine the duration of suppressive treatment before recovery of thyroid stimulating hormone secretion.

Authors:  H R Fischer; W H Hackeng; W Schopman; J Silberbusch
Journal:  Clin Endocrinol (Oxf)       Date:  1982-06       Impact factor: 3.478

9.  Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine.

Authors:  C J Edmonds; S Hayes; J C Kermode; B D Thompson
Journal:  Br J Radiol       Date:  1977-11       Impact factor: 3.039

10.  Acute thyroid hormone withdrawal rapidly increases the thyrotropin beta and alpha-subunit messenger ribonucleic acids in mouse thyrotropic tumors.

Authors:  D S Ross; M F Ellis; E C Ridgway
Journal:  Endocrinology       Date:  1986-03       Impact factor: 4.736

View more
  1 in total

1.  Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes.

Authors:  I C Roura-Mir; L Alcalde; F Vargas; E Tolosa; G Obiols; M Foz; D Jaraquemada; R Pujol-Borrell
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.